Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-24-126521

Chief Executive Officer sold 30,000 shares at an average $55.62 ($1,668,678)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2024-11-11 Sale 10b5-1 −23,121 $55.43 $1,281,597 203,419 D: show line 1 in the form
Kulkarni Samarth Chief Executive Officer 2024-11-11 Sale 10b5-1 −6,879 $56.27 $387,081 196,540 D: show line 2 in the form
Open-market sales · 30,000 sh · avg $55.62 · $1,668,678
Loading xslF345X05/ownership.xml…